Haemodynamic effects of ketanserin in the treatment of hypertension following CABG: a double-blind, placebo-controlled study.
Vandenbroucke
G
G
Department of Cardiac Anaesthesia, O.L. Vrouwkliniek, Aalst, Belgium.
Foubert
L
L
Evenepoel
M C
MC
D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D002496:Central Venous Pressure / Q000187:drug effects; D001026:Coronary Artery Bypass / Q000009:adverse effects*; D004311:Double-Blind Method; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000517:prevention & control*; D007650:Ketanserin / Q000008:administration & dosage / Q000627:therapeutic use*; D010919:Placebos; D011669:Pulmonary Wedge Pressure / Q000187:drug effects; D013318:Stroke Volume / Q000187:drug effects; D014655:Vascular Resistance / Q000187:drug effects
D010919:Placebos; D007650:Ketanserin